Sotatercept Tied to Disease Modification in PAH
Data show sotatercept may deliver significant clinical benefits and could reshape the trajectory of this challenging disease.
Stay updated with breaking news from Altavant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data show sotatercept may deliver significant clinical benefits and could reshape the trajectory of this challenging disease.
/PRNewswire/ -- DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...
/PRNewswire/ -- The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering....
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to ...
Vivek Ramaswamy, the founder and former CEO of Roivant Sciences (ROIV), is considering a bid for the Republican presidential nomination, POLITICO reported.